10 min listen
Treatment of Peripheral Artery Disease
ratings:
Length:
15 minutes
Released:
Oct 4, 2022
Format:
Podcast episode
Description
In this JAMA Author Interview, JAMA Interim Executive Editor Greg Curfman, MD, speaks with Mary M. McDermott, MD, professor of medicine at Northwestern University Feinberg School of Medicine, on current therapies for peripheral artery disease and a new clinical trial she directed on the use of telmisartan, an angiotensin receptor blocker, for patients with peripheral artery disease. Related Content: Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease
Released:
Oct 4, 2022
Format:
Podcast episode
Titles in the series (100)
A Physician Management Infrastructure: Interview with Peter J. Pronovost, MD, PhD, author of A Physician Management Infrastructure by JAMA Author Interviews